Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

Data as of Oct 23
 +0.007 / +1.32%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company that is engaged in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.
12390 El Camino Real
San Diego California 92130
P:(858) 552-0866
Investor Relations:



Other institutional4.56%
Mutual fund holders12.34%
Individual stakeholders0.34%

Top Executives

Brian M. CulleyChief Executive Officer & Director
Patrick L. KeranPresident, Chief Operating Officer & Secretary
Brandi L. RobertsChief Financial Officer, CAO & Senior VP
Edwin L. ParsleyChief Medical Officer & Senior Vice President
Robert Martin EmanueleSenior Vice President-Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.